Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: A prospective study

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 1, 2001, Pages 43-50

  Wiström, Johan ^a   Norrby, S Ragnar ^b   Myhre, Erling B ^b   Eriksson, Sverker ^c   Granström, Gunnar ^d   Lagergren, Lillemor ^e   Englund, Gunnar ^e   Nord, Carl Erik ^f   Svenungsson, Bo ^f  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Norrköping Hospital   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

^e Astra Läkemedel AB   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFADROXIL; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN B; COTRIMOXAZOLE; GLYCOPEPTIDE; IMIDAZOLE DERIVATIVE; LAXATIVE; LORACARBEF; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DRUG INDUCED DISEASE; DRUG USE; ENDOSCOPY; ENTERITIS; FECES ANALYSIS; FEMALE; FREQUENCY ANALYSIS; GENDER; GERIATRICS; HOSPITAL PATIENT; HUMAN; INFECTION; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROLOGY; ORTHOPEDICS; PROSPECTIVE STUDY; RISK; SURGERY; SWEDEN; WARD;

EID: 0035180464     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.1.43     Document Type: Article

References (29)

1. Mechanisms and management of antibiotic-associated diarrhea
2. Epidemiological aspects of infections caused by Bacteroides fragilis and Clostridium difficile
3. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas
4. Clinical impact and associated costs of Clostridium difficile-associated disease
5. Medical implications of nosocomial infection with Clostridium difficile
6. Financial burden of hospital-acquired Clostridium difficile infection
7. Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea
8. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease
9. Risk factors for Clostridium difficile infection
10. Clostridium difficile and antibiotic associated diarrhoea in Sweden
11. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime
12. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use
13. Clostridium difficile in faecal flora after perioperative prophylaxis with ampicillin or ceftriaxone
14. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
15. Prevention of β-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
16. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
17. Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, β-lactams, or nonantibiotic medications
18. Antimicrobial agents and Clostridium difficile in acute enteric disease: Epidemiological data from Sweden, 1980-1982
19. Nosocomial acquisition of Clostridium difficile infection
20. Effects of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
21. The epidemiology and typing of Clostridium difficile
22. Intestinal colonization with Clostridium difficile in infants up to 18 months of age
23. Infection due to Clostridium difficile among elderly residents of a long-term-care facility
24. Clostridium difficile colonization and diarrhea at a tertiary care hospital
25. Acquisition of Clostridium difficile by hospitalized patients: Evidence for colonized new admissions as a source of infection
26. Presence of Clostridium difficile and antibiotic and β-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo
27. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden
28. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients
29. The relationship between an increase in β-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances